No profile data available.
Quoin Pharmaceuticals, Ltd. (QNRX) is a healthcare company in the skin treatment pharmaceuticals industry, based in Ashburn, United States, with about 4 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$15.80 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $21.62 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.
Quoin Pharmaceuticals reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$21.62 million as of October 9, 2026.
Listed companies of a similar size in the same industry (skin treatment pharmaceuticals) include Sol-Gel Technologies Ltd. (SLGL), Journey Medical Corporation (DERM), Fortress Biotech, Inc. (FBIO), Biofrontera Inc. (BFRI).